Trial · NCT03229538
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 97 | 12 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 97 | 17 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 96 | 3 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 96 | 7 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 95 | 4 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 95 | 8 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 94 | 44 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 94 | 36 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 93 | 12 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 93 | 30 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 92 | 24 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 92 | 22 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 91 | 4 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 91 | 2 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 81-90 | 0 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 81-90 | 1 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 71-80 | 0 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 71-80 | 0 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Methylprednisolone Arm | Rank = 61-70 | 2 | Participants | |
| Number of Participants at Each Global Rank Endpoint Based Upon Their Most-severe Outcome | Placebo Arm | Rank = 61-70 | 5 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03229538/results